The MIT Startup Exchange Lightning Talks and Startup Exhibit listed below are part of the full agenda for 2023 MIT Health Science Technology Conference.
This conference will explore new or improved therapeutic approaches for finding cures for diseases which traditionally have been difficult to treat. This includes technologies for optimizing treatments and monitoring efficacy based on insights into cell and tissue state, circuitry, behavior, function, and responsiveness in normal and disease states, biomarker detection, better methods to predict and track efficacy, and enhanced manufacturing capabilities.
Director, MIT Startup Exchange
Catarina Madeira joined Corporate Relations in May 2021 as Program Director, Startup Exchange.
Madeira has been working with the Cambridge/Boston startup ecosystem for the past 10 years and joins Corporate Relations with a solid network in the innovation and entrepreneurial community. In 2010, she joined the startup accelerator IUL MIT Portugal working in Lisbon and working with the Cambridge team on all aspects related to the accelerator’s launch. She held positions including Operations Coordinator, Program Manager, and Business Developer. The accelerator soon achieved steady growth in large part due to the partnerships that Catarina led with regional and global startup ecosystems. Most recently she worked at NECEC, leading a program that connects cleantech startups and industry. In this role, she developed and built a pipeline of startups and forged strong relationships with both domestic and European companies. She has also held positions in Portugal and France including at L’Oréal and Saboaria e Perfumaria Confiança as Pharmacist and Technical Director.
Madeira earned her Bachelor in Chemistry at the University of Porto and her Bachelor in Pharmaceutical Sciences at the University of Coimbra in Portugal. She went on to earn her Master of Engineering for Health and Medicines at University Lyon 1 and EM Lyon in France.
VP of Corporate Development & Co-Founder , 4M Therapeutics
CEO, Decoy Therapeutics
Co-Founder & CEO, DxLab
Founder and CEO, Ketryx Corporation
SVP and Chief Technology Officer, Replay Holdings
Director of R&D, Sunflower Therapeutics
Co - founder and CEO, Stratagen Bio
Co-Founder and Chief Scientist, Tiba Biotech
Chief Executive Officer, Vivtex
Disclaimer: MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.